Haemonetics (HAE) Announces CFO Will Step Down in June 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Haemonetics (HAE) PT Lowered to $80 at Jefferies
November 10, 2021 8:10 AM ESTJefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $80.00 (from $85.00) while maintaining a Buy rating.
The analyst commented, "Key updates from the call: 1) US plasma volumes improved to +20% (+14% last Q), 2) Nov volumes flat at +20% (high-end of revised... More
